Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Small Cell Lung Cancer Extensive Stage × NPI 2358 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Cancer Extensive Stage 1

Interventions

Etoposide 3 Carboplatin 3 atezolizumab 2 tislelizumab 1 pembrolizumab 1 irinotecan sucrosofate 1 apatinib 1 Radiotherapy 1 Platinum 1 NPI 2358 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05745350 2025-02-11

First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡